Improved telomerase mapping may aid developmen... - CLL Support

CLL Support

23,137 members39,744 posts

Improved telomerase mapping may aid development of anti-cancer drugs

AussieNeil profile image
AussieNeilPartnerAdministrator
2 Replies

Researchers at UC Berkeley have now mapped out the structure of telomerase using record high resolution images. 'According to the team, these high-resolution images, along with our current understanding of the telomerase gene sequence, is enough to start thinking about potential drug targets related to the enzyme. Finding ways to increase the activity of telomerase, for example, could help stave off the negative effects of aging for longer, while blocking its function could help fight cancer, which often hijacks telomerase to make its own cells essentially "immortal."'

newatlas.com/telomerase-enz...

Previous posts on the role of telomeres and CLL can be found here: healthunlocked.com/search/t...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
2 Replies
Jm954 profile image
Jm954Administrator

Preserving telomere length.....the holy grail.

cllady01 profile image
cllady01Former Volunteer

If we could only find the "do not delete" button.

Not what you're looking for?

You may also like...

High Alkaline Phosphatase

I had bloodwork recently, for a physician other than my CLL Specialist, who told me today that one...

Cancer Lottery - campaign asking for fair consideration of new drugs required to treat rarer cancer patients in the UK

Many will have been following the unsatisfactory way in which new drugs for CLL are being assessed...

Welcome and information about polls to aid in the development of the CLLSA website: http://www.cllsupport.org.uk

Welcome everyone, what an incredible response to the launch of our new on-line community. Thank you...

Which monoclonal antibody would work with omicron covid 19?

Which monoclonal antibody would work with omicron covid 19? Reposted from CLLSLL@groups.io :...

Five-year results for the iFCG regimen: first-line treatment of CLL patients with mutated IGHV and without del(17p)/TP53 mutation

Published 4 months ago,...